Revenue Increased 7% Year-over-Year to $31.7 Million Repaid $25 Million of Outstanding Credit Facility Continued Expansion of Joint Preservation Product Portfolio BEDFORD, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a …
WARSAW, Indiana, Nov. 04, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a Company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third …
SUNRISE, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- FedNat Holding Company (Nasdaq: FNHC), a regional insurance holding company, today announced that its Board of Directors declared a quarterly dividend of $0.09 per share of FedNat common stock, payable on …
Committee Retains Piper Sandler as Financial Advisor SUNRISE, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- FedNat Holding Company (NASDAQ:FNHC) (“FedNat” or the “Company”), a regional insurance holding company, announced today that the Company’s Board of …
BOSTON, Nov. 04, 2020 (GLOBE NEWSWIRE) -- First Eagle Alternative Capital BDC, Inc. (formerly known as THL Credit, Inc.) (NASDAQ: FCRD) (“First Eagle Alternative Capital BDC” or the “Company”), a direct lender to middle market companies, today announced …
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today reported financial results for the third …
Net Revenues of $1,115.7 million, up 148.5% year-over-year on an FX neutral basis $14.5 billion Total Payment Volume, up 161.2% year-over-year on an FX neutral basis $5.9 billion Gross Merchandise Volume, up 117.1% year-over-year on an FX neutral basis …
Three accepted abstracts will be presented virtually in a pre-recorded poster session MONT-SAINT-GUIBERT, Belgium, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the …
- New Drug Application (NDA) for trilaciclib in small cell lung cancer accepted for Priority Review with a PDUFA action date of February 15, 2021 - Announced CEO succession plan in evolution to commercial-stage company - Management to host webcast …
ROCKVILLE, Md., Nov. 04, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …
SAN FRANCISCO, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that it will present data on its novel targeted protein degradation platform …
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenue Net new business of $986.0 million; Net book-to-bill of 1.35 including reimbursement revenue $796.3 million of total revenue; …
Company reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $23.7 million in third quarter 2020 BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported …
Net Third Quarter Revenues of $48.0 Million Increased 33% Year-Over-Year, Driven by $18.4 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing Company Has Submitted EUA Application For Its Lab-based Oral Fluid SARS-CoV-2 …
MIDLAND, Texas, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rattler Midstream LP (NASDAQ: RTLR) (“Rattler” or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced financial and operating results for the third …
CAMBRIDGE, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced it will present …
Digital content revenues increased 67% year-over-year Exceeded previous guidance for 3rd Quarter Adjusted EBITDA CHICAGO, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Tribune Publishing Company (NASDAQ: TPCO) today announced financial results for the third quarter …
SUNRISE, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- FedNat Holding Company (the “Company”) (Nasdaq: FNHC) today reported results for the three and nine months ended September 30, 2020. Q3 2020 highlights (as measured against the same three-month period last …
LEXINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from …
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- TCG BDC, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “TCG BDC” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its third quarter ended September 30, 2020. …
